Epidemiology and Study Design Practice Flashcards

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/51

flashcard set

Earn XP

Description and Tags

Comprehensive vocabulary flashcards covering basic epidemiology modules including study types, measures of frequency and association, bias, confounding, measurement error, RCTs, outbreak investigation, systematic reviews, and screening.

Last updated 9:58 PM on 5/29/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

52 Terms

1
New cards

Descriptive Study

A study that measures a single variable and does not look at the association between two factors.

2
New cards

Analytic Study

A study that compares two variables and assesses their correlation to infer causation.

3
New cards

Randomised control trial (RCT)

The strongest primary study design involving random allocation of participants to exposure groups to balance confounders and directly test causality.

4
New cards

Cohort Study

An observational study with non-random allocation into groups based on exposure, where subjects are followed over time to calculate incidence and relative risk.

5
New cards

Case-control Study

A study where groups are selected based on the presence (case) or absence (control) of an outcome, looking back at exposure.

6
New cards

Study Base

The foundation of a case-control study defined by the place participants come from, the timeframe, and the person characteristics.

7
New cards

Cross-sectional Study

A study where exposure and outcome data are selected at the same time, measuring prevalence but unable to establish temporality or causality.

8
New cards

Ecological Study

A study that compares two variables at the population level rather than the individual level.

9
New cards

Ecological Fallacy

A limitation where associations found at the group level may not hold true at the individual level.

10
New cards

Crossover Trial

A study design where outcomes among an exposed group are compared to themselves when unexposed, meaning subjects serve as their own control.

11
New cards

Systematic Review (with meta-analysis)

The highest level of evidence that synthesises all high-quality studies on a question using reproducible methods and pools data to reduce random error.

12
New cards

Prevalence

The proportion of a population with an existing disease at a specific point or period in time; expressed as # of people with attribute at time pointtotal pop. at time point\frac{\text{\# of people with attribute at time point}}{\text{total pop. at time point}}.

13
New cards

Incidence

A true rate measuring how quickly people newly develop a disease during a specified period.

14
New cards

Person-time

The length of time people are at risk of a disease, measured in units like person-years, person-months, or person-days.

15
New cards

Incidence Density

Also known as incidence rate, calculated as # new casestotal person-time\frac{\text{\# new cases}}{\text{total person-time}}, often expressed per 100,000100,000 person-years.

16
New cards

Incidence Proportion

The proportion of people at risk who develop disease during a specified period; also known as cumulative incidence or attack rate.

17
New cards

Symptom

Subjective indications of disease reported by the person.

18
New cards

Sign

Objective indications of disease apparent to the physician.

19
New cards

Rate Ratio / Relative Risk (RR)

An association measure indicating how much higher the rate of disease is in the exposed vs non-exposed; RR>1RR > 1 indicates a risk factor.

20
New cards

Risk Difference (RD) / Absolute Risk Reduction (ARR)

The difference in incidence between the exposed and unexposed groups (incidence in exposedincidence in unexposed\text{incidence in exposed} - \text{incidence in unexposed}).

21
New cards

Odds Ratio (OR)

A measure of association used in case-control studies or cross-sectional analytic studies, especially when the outcome is rare.

22
New cards

Population Attributable Risk (PAR)

How much disease in the whole community can be attributed to a specific exposure.

23
New cards

Attributable Fraction (AF)

The proportion of outcomes in the exposed group that are specifically due to the exposure, calculated as Risk DifferenceIncidence in exposed\frac{\text{Risk Difference}}{\text{Incidence in exposed}}.

24
New cards

Number Needed to Treat (NTT)

The number of patients required to be given experimental therapy to prevent one adverse event, calculated as 1ARR\frac{1}{\text{ARR}}.

25
New cards

Selection Bias

A systematic error resulting in a wrong result due to differences between people who are part of a study versus those who are not.

26
New cards

Intention to Treat Analysis

A methodology where all participants are analysed in the groups to which they were originally randomised, regardless of compliance, to preserve randomisation.

27
New cards

Confounding

A distortion of effects occurring when the relationship between exposure and outcome is confused by a third factor associated with both.

28
New cards

Stratification

The process of dividing study participants into separate groups (strata) based on a third variable to calculate separate association measures.

29
New cards

Effect Modification

A situation where the effect of one factor on an outcome depends on the presence or absence of a second factor.

30
New cards

Direct Standardisation

Applying variable-specific rates from a study population to a single, agreed-upon standard population to produce a standardised rate.

31
New cards

Indirect Standardisation

Applying variable-specific rates from a reference population to the study population to produce a Standardised Incidence Ratio (SIR).

32
New cards

Measurement Bias

Systematic error in estimated frequency or effect caused by measurement error or misclassification of factors.

33
New cards

Validity

The degree to which a measurement or test accurately measures what it is supposed to measure.

34
New cards

Reliability / Repeatability

The ability of a test to produce the same result when used repeatedly to measure the same factor.

35
New cards

Sensitivity

The proportion of people who have the outcome that receive a positive test result (Positive testPositive outcome\frac{\text{Positive test}}{\text{Positive outcome}}).

36
New cards

Specificity

The proportion of people who do not have the outcome that receive a negative test result (Negative testNegative outcome\frac{\text{Negative test}}{\text{Negative outcome}}).

37
New cards

Positive Predictive Value (PPV)

The proportion of people with a positive test who truly have the outcome (Positive OutcomePositive test\frac{\text{Positive Outcome}}{\text{Positive test}}), which depends on disease prevalence.

38
New cards

Non-differential Error

When the same scale of measurement error exists in each study group, nearly always biasing results towards the null.

39
New cards

Differential Error

When the measurement error differs between study groups, which can bias results towards or away from the null.

40
New cards

Allocation Concealment

The process of hiding the group to which a subject is allocated from the person recruiting them to prevent selection bias.

41
New cards

Publication Bias

A bias occurring when studies are published or not based on the significance or direction of their results.

42
New cards

Endemic

The constant presence or baseline level of a disease or infectious agent in a specific geographic area or group.

43
New cards

Epidemic

Occurrence of a disease in a specific area and time period above the normal expected baseline.

44
New cards

Outbreak

An epidemic limited to a localized increase in disease incidence, such as in a school or hospital.

45
New cards

Pandemic

An epidemic occurring worldwide or over a very large geographic region across international boundaries.

46
New cards

Case Definition

Specific criteria (time, place, person, clinical/lab findings) used to identify who counts as a 'case' during an investigation.

47
New cards

Forest Plot

A graphical representation used in meta-analyses where boxes represent individual studies and a diamond represents the pooled estimate.

48
New cards

Heterogeneity (I2I^{2})

A measure of inconsistency between studies in a systematic review; values of 75100%75-100\% represent considerable heterogeneity.

49
New cards

Lead Time Bias

Bias occurring when survival time appears longer following screening because detection was earlier, even though the actual time of death remains unchanged.

50
New cards

Length Time Bias

The tendency for screening to preferentially detect slowly progressive diseases because they have a longer window to be picked up.

51
New cards

Wilson and Jungner Principles

The established set of requirements for a screening program, including that the condition must be an important health problem and treatment must be more effective before symptoms occur.

52
New cards

Volunteer bias

Bias arising from the fact that volunteers are generally more healthier